The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Wed, 23rd Sep 2020 16:13

Thursday 24 September 
Kainos Group PLCAGM
Alcentra European Floating Rate Income Fund LtdAGM
Securities Trust of ScotlandAGM
Sure Ventures PLCAGM
Triad Group PLCAGM
Versarien PLCAGM
Shearwater Group PLCAGM
Vertu Capital LtdAGM
Premier Veterinary Group PLCGM - acquisition and delisting
British & American Investment Trust PLCAGM
Caffyns PLCAGM
Miton Global Opportunities PLCAGM
Securities Trust of Scotland PLCAGM
Friday 25 September 
Schroder Real Estate Investment Trust LtdAGM
Star Phoenix Group LtdEGM re director removals
Catenae Innovation PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Marble Point Loan Financing PLCAGM
Fusion Antibodies PLCAGM
Solo Oil PLCAGM
Lekoil LtdAGM
Hydrogen Group PLCGM re delisting
Okyo Pharma LtdAGM
India Capital Growth Fund LtdAGM
Stagecoach Group PLCAGM
Monday 28 September 
Diageo PLCAGM
Time Out Group PLCAGM
Mulberry Group PLCAGM
Van Elle Holdings PLCAGM
Mereo BioPharma Group PLCAGM
Christie Group PLCAGM
Galileo Resources PLCAGM
Eddie Stobart Logistics PLCGM re financial statements
Challenger Acquisitions LtdAGM
Avon Rubber PLCGM re Team Wendy purchase
Tuesday 29 August 
PV Crystalox Solar PLCGM re tender offer
Raven Property Group LtdGM re tender offer
Novacyt SAAGM
Gama Aviation PLCAGM
Ince Group PLCAGM
IMImobile PLCAGM
Brickability Group PLCAGM
DCD Media PLCAGM
Jaywing PLCAGM
Carclo PLCAGM
Arcontech Group PLCAGM
Amigo Holdings PLCGM re Richmond Group resolutions
Rockfire Resources PLCGM re articles of association amendment
Appreciate Group PLCAGM
Augmentum Fintech PLCAGM
Wednesday 30 September 
Active Energy Group PLCAGM
Anglesey Mining PLCAGM
Catena Group PLCAGM
Chenvari Capital Solutions LtdEGM - re base currency change to euro
City of London Group PLCAGM
Clipper Logistics PLCAGM
Creightons PLCAGM
daVictus PLCAGM
Distribution Finance Capital Holdings PLCAGM
HML Holdings PLCAGM
IntegraFin Holdings PLCGM re hybrid general meetings
Marlowe PLCAGM
Mobile Tornado Group PLCAGM
Motif Bio PLCAGM
Powerhouse Energy Group PLCAGM
Purplebricks Group PLCAGM
Renishaw PLCAGM
San Leon Energy PLCAGM
Sosandar PLCAGM
Studio Retail Group PLCAGM
Tekmar Group PLCAGM
TheWorks.co.uk PLCAGM
Yew Grove REIT PLCEGM re gearing level
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2019 10:31

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Read more
10 Oct 2019 11:52

Motif Bio Meeting With US FDA Confirms Need For Another iclaprim Trial

Motif Bio Meeting With US FDA Confirms Need For Another iclaprim Trial

Read more
2 Oct 2019 11:59

Motif Bio To Raise GBP600,000 Via Placing To Fund Major Restructure

Motif Bio To Raise GBP600,000 Via Placing To Fund Major Restructure

Read more
1 Oct 2019 17:09

Motif Bio To Become Cash Shell If Restructuring Proposals Accepted

Motif Bio To Become Cash Shell If Restructuring Proposals Accepted

Read more
2 Sep 2019 11:39

Motif Bio Delays Next Amortisation Date Of Hercules Loan Facility

(Alliance News) - Novel antibiotics-focused biopharmaceutical company Motif Bio PLC said Monday it has agreed with Hercules Capital Inc to postpone the next amortisation date for its loan and date

Read more
19 Aug 2019 10:46

WINNERS & LOSERS SUMMARY: IXICO Rises On Positive Outlook

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------J up 3.8%. The is

Read more
19 Aug 2019 09:29

Motif Bio Receives US State Funding For Iclaprim Listeria Study

(Alliance News) - Biopharmaceutical firm Motif Bio PLC said Monday that the US government will fund a study on the effectiveness of the iclaprim drug against listeria monocytogenes.Shares a

Read more
1 Aug 2019 11:43

Motif Bio Postpones Next Amortisation Date Of Hercules Loan Facility

(Alliance News) - Biopharmaceutical firm Motif Bio PLC said on Thursday has amended its loan agreement with Hercules Capital Inc, delaying the next amortisation date by one month to September a to

Read more
12 Jun 2019 18:16

Amphion Innovations To Work With Debt Providers To Refinance Facility

(Alliance News) - Amphion Innovations PLC said Wednesday its debt providers have told the company the excess value of the collateral does not meet the terms of an agreed facility between the in at

Read more
6 Jun 2019 10:47

WINNERS & LOSERS SUMMARY: Rolls Royce And L&G Rise On Pension Pact

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Rolls up

Read more
31 May 2019 15:32

Motif Bio Shareholders Reject Remuneration Report Resolution

LONDON (Alliance News) - Motif Bio PLC on Friday said that shareholders voted against approval of the company's remuneration report.At the clinical-stage biopharmaceutical firm's on

Read more
1 May 2019 10:46

Motif Bio to work with Lamellar on cystic fibrosis treatment possibility

(Sharecast News) - Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with Lamellar Biomedical, under which Motif Bio would conduct an in vivo preclinical study evaluating iclaprim in combination with Lamellar's patented 'Lamellasome' technology.

Read more
1 May 2019 09:26

Motif Bio Shares Up On Agreement With Lamellar To Start Clinical Study

LONDON (Alliance News) - Shares rose in Motif Bio PLC on Wednesday as it signed an agreement with Lamellar Biomedical to study the combination of Motif's iclaprim with Lamellar's in the at

Read more
26 Apr 2019 14:09

Motif Bio Appoints Andrew Powell As Non-Executive Director

LONDON (Alliance News) - Motif Bio PLC, a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, said Friday it has appointed Andrew Powell as non-executive has as

Read more
15 Apr 2019 10:50

Motif Bio 2018 Loss Narrows As Research Costs Fall Despite US Delay

LONDON (Alliance News) - Motif Bio PLC said Monday its 2018 loss narrowed significantly as research costs fell, despite an unexpected delay in its new drug application in the US.In 2018, to

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.